173 related articles for article (PubMed ID: 24679922)
21. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
23. The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.
Di Ciano P; Cormick PM; Stefan C; Wong E; Kim A; Remington G; Le Foll B
Psychopharmacology (Berl); 2017 Nov; 234(22):3309-3320. PubMed ID: 28825117
[TBL] [Abstract][Full Text] [Related]
24. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
25. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
Shotbolt P; Tziortzi AC; Searle GE; Colasanti A; van der Aart J; Abanades S; Plisson C; Miller SR; Huiban M; Beaver JD; Gunn RN; Laruelle M; Rabiner EA
J Cereb Blood Flow Metab; 2012 Jan; 32(1):127-36. PubMed ID: 21878947
[TBL] [Abstract][Full Text] [Related]
26. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
[TBL] [Abstract][Full Text] [Related]
27. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
[TBL] [Abstract][Full Text] [Related]
28. Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.
Matuskey D; Worhunksy P; Correa E; Pittman B; Gallezot JD; Nabulsi N; Ropchan J; Sreeram V; Gudepu R; Gaiser E; Cosgrove K; Ding YS; Potenza MN; Huang Y; Malison RT; Carson RE
Neuroimage; 2016 Apr; 130():241-247. PubMed ID: 26876475
[TBL] [Abstract][Full Text] [Related]
29. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ
J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
[TBL] [Abstract][Full Text] [Related]
31. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.
Bergman J; Roof RA; Furman CA; Conroy JL; Mello NK; Sibley DR; Skolnick P
Int J Neuropsychopharmacol; 2013 Mar; 16(2):445-58. PubMed ID: 22827916
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.
Leggio GM; Torrisi SA; Castorina A; Platania CB; Impellizzeri AA; Fidilio A; Caraci F; Bucolo C; Drago F; Salomone S
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1427-36. PubMed ID: 25482686
[TBL] [Abstract][Full Text] [Related]
33. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
34. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
35. PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration.
Allen MI; Duke AN; Nader SH; Adler-Neal A; Solingapuram Sai KK; Reboussin BA; Gage HD; Voll RJ; Mintz A; Goodman MM; Nader MA
Neuropsychopharmacology; 2023 Sep; 48(10):1436-1445. PubMed ID: 37349473
[TBL] [Abstract][Full Text] [Related]
36. The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.
Quelch DR; Withey SL; Nutt DJ; Tyacke RJ; Parker CA
Neuropharmacology; 2014 Oct; 85(100):305-13. PubMed ID: 24910074
[TBL] [Abstract][Full Text] [Related]
37. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
[TBL] [Abstract][Full Text] [Related]
38. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
39. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
[TBL] [Abstract][Full Text] [Related]
40. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.
Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A
Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
